Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population

Figure 3

ROC curves of plasma fibulin-3 for distinguishing patients with asbestos-related diseases (ARDs) from AE subjects or healthy controls. Four ROCs with high AUC (>0.800) were selected and are shown in (a), (b), (c), and (d). ROC: receiver operating characteristic; AE: asbestos-exposed subjects; AUC: area under the curve.

(a)

(b)

(c)

(d)